Prosthetic Mitral Valve Fungal Endocarditis
Fungal prosthetic valve endocarditis is described in a patient without significant comorbidities. Key questions guiding the discussion include the following. 1) What are the diagnostic criteria and major differential diagnoses? 2)What are the current surgical indications and optimal timing for prost...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | JACC: Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666084925006461 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849426097983193088 |
|---|---|
| author | André L. Tyszka, MD Maria Emilia A. Machado, MD Harissa S. El Ghoz, MS Giovanna S. Tyszka, MS Mateus A. Aboboreira, MS Alexandro J. Jorge, MD Rogerio M. Gaspar, MD Paola C. Souza, MD |
| author_facet | André L. Tyszka, MD Maria Emilia A. Machado, MD Harissa S. El Ghoz, MS Giovanna S. Tyszka, MS Mateus A. Aboboreira, MS Alexandro J. Jorge, MD Rogerio M. Gaspar, MD Paola C. Souza, MD |
| author_sort | André L. Tyszka, MD |
| collection | DOAJ |
| description | Fungal prosthetic valve endocarditis is described in a patient without significant comorbidities. Key questions guiding the discussion include the following. 1) What are the diagnostic criteria and major differential diagnoses? 2)What are the current surgical indications and optimal timing for prosthetic valve endocarditis? 3) How do mortality prediction scores inform surgical decision-making through risk stratification? 4) What medical treatment should be initiated, and what is the most appropriate antifungal regimen once the etiologic agent is identified? 5) What strategies ensure long-term follow-up and prevention of postoperative fungal reinfection? After initial antibiotic failure, the patient underwent successful reoperation, leading to the diagnosis of fungal infection, which was appropriately treated with antifungal therapy. Take-Home Messages: This case underscores the complexity of diagnosing fungal endocarditis and its high mortality risk, highlighting the critical role of a multidisciplinary team in achieving optimal management. |
| format | Article |
| id | doaj-art-077262707f1c42ca8d2ebb0fa47736bb |
| institution | Kabale University |
| issn | 2666-0849 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JACC: Case Reports |
| spelling | doaj-art-077262707f1c42ca8d2ebb0fa47736bb2025-08-20T03:29:34ZengElsevierJACC: Case Reports2666-08492025-07-01301710386810.1016/j.jaccas.2025.103868Prosthetic Mitral Valve Fungal EndocarditisAndré L. Tyszka, MD0Maria Emilia A. Machado, MD1Harissa S. El Ghoz, MS2Giovanna S. Tyszka, MS3Mateus A. Aboboreira, MS4Alexandro J. Jorge, MD5Rogerio M. Gaspar, MD6Paola C. Souza, MD7Cardiac Surgery Department, Hospital Parana, Maringa-PR, Brazil; Address for correspondence: Dr André Luiz Tyszka, Department of Cardiac Surgery, Parana Hospital, Av Laguna 733 apto 502, CEP 87050-260, Maringá-PR Brazil.Cardiac Surgery Department, Hospital Parana, Maringa-PR, BrazilFaculdade Inga, Maringa-PR, BrazilCentro Universitário Unicesumar, Maringa-PR, BrazilUniversidade Estadual de Maringa, Maringa-PR, BrazilCardiac Surgery Department, Hospital Parana, Maringa-PR, BrazilCardiac Surgery Department, Hospital Parana, Maringa-PR, BrazilLaboratorio de Anatomia Patologica Souza, Maringa-PR, BrazilFungal prosthetic valve endocarditis is described in a patient without significant comorbidities. Key questions guiding the discussion include the following. 1) What are the diagnostic criteria and major differential diagnoses? 2)What are the current surgical indications and optimal timing for prosthetic valve endocarditis? 3) How do mortality prediction scores inform surgical decision-making through risk stratification? 4) What medical treatment should be initiated, and what is the most appropriate antifungal regimen once the etiologic agent is identified? 5) What strategies ensure long-term follow-up and prevention of postoperative fungal reinfection? After initial antibiotic failure, the patient underwent successful reoperation, leading to the diagnosis of fungal infection, which was appropriately treated with antifungal therapy. Take-Home Messages: This case underscores the complexity of diagnosing fungal endocarditis and its high mortality risk, highlighting the critical role of a multidisciplinary team in achieving optimal management.http://www.sciencedirect.com/science/article/pii/S2666084925006461cardiovascular diseaseendocarditisvalve replacement |
| spellingShingle | André L. Tyszka, MD Maria Emilia A. Machado, MD Harissa S. El Ghoz, MS Giovanna S. Tyszka, MS Mateus A. Aboboreira, MS Alexandro J. Jorge, MD Rogerio M. Gaspar, MD Paola C. Souza, MD Prosthetic Mitral Valve Fungal Endocarditis JACC: Case Reports cardiovascular disease endocarditis valve replacement |
| title | Prosthetic Mitral Valve Fungal Endocarditis |
| title_full | Prosthetic Mitral Valve Fungal Endocarditis |
| title_fullStr | Prosthetic Mitral Valve Fungal Endocarditis |
| title_full_unstemmed | Prosthetic Mitral Valve Fungal Endocarditis |
| title_short | Prosthetic Mitral Valve Fungal Endocarditis |
| title_sort | prosthetic mitral valve fungal endocarditis |
| topic | cardiovascular disease endocarditis valve replacement |
| url | http://www.sciencedirect.com/science/article/pii/S2666084925006461 |
| work_keys_str_mv | AT andreltyszkamd prostheticmitralvalvefungalendocarditis AT mariaemiliaamachadomd prostheticmitralvalvefungalendocarditis AT harissaselghozms prostheticmitralvalvefungalendocarditis AT giovannastyszkams prostheticmitralvalvefungalendocarditis AT mateusaaboboreirams prostheticmitralvalvefungalendocarditis AT alexandrojjorgemd prostheticmitralvalvefungalendocarditis AT rogeriomgasparmd prostheticmitralvalvefungalendocarditis AT paolacsouzamd prostheticmitralvalvefungalendocarditis |